Basil Drugs Private Limited - Company Profile

It is a pharma private limited company based in Indore, Madhya Pradesh, India, established in 2001.
2001 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Basil Drugs Private Limited

Basil Drugs Private Limited, a active private limited company, was established on 16 April 2001 in Indore, Madhya Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232MP2001PTC014624. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Formerly known as Basil Drugs Limited. It upholds a compliant status. Its leadership includes Rajesh Kumar Singh (Managing Director), Tara Kushwaha (Whole-Time Director), Mohammad Shakil Sheikh (Whole-Time Director). Past directors included Rajesh Kumar Singh, Manish Kumar Jain, Tara Kushwaha. It holds ₹0.68 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at N- 60, Anoop Nagar, Indore, Madhya Pradesh, 452011.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232MP2001PTC014624

  • Registration Number

    014624

  • Incorporation Date

    16 April 2001

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 24 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 0.68 M
  • Revenue Growth **** 4.80%
  • Profit Growth **** -5.95%
  • Ebitda **** -10.33%
  • Net Worth 9.19%
  • Total Assets -13.73%
Company report

Basil Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Basil Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Basil Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajesh Kumar Singh Managing Director 16 Apr 2001 Current
Tara Kushwaha Whole-Time Director 16 Apr 2001 Current
Mohammad Shakil Sheikh Whole-Time Director 30 Sep 2007 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Oct 2013 Past
Pramod Abcsdd Director 15 Apr 2010 Past
Pramod Abcsdd Director 01 Oct 2013 Past
Pramod Abcsdd Director 01 Oct 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Basil Drugs.

Basil Drugs Private Limited, for the financial year ended 2016, experienced modest growth in revenue, with a 4.8% increase. The company also saw a slight decrease in profitability, with a 5.95% decrease in profit. The company's net worth moved up by a moderate rise of 9.19%.

Basil Drugs revenue growth over time
Basil Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 4.80%
*******
*******
*******
*******
Revenue from Operations
*******
 4.79%
*******
*******
*******
*******
Total Assets
*******
 -13.73%
*******
*******
*******
*******
Profit or Loss
*******
 -5.95%
*******
*******
*******
*******
Net Worth
*******
 9.19%
*******
*******
*******
*******
EBITDA
*******
 -10.33%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Basil Drugs?

In 2017, Basil Drugs had a promoter holding of 51.09% and a public holding of 48.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹683,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.03 Cr
  • Icici Bank Limited : 0.02 Cr
  • State Bank Of Indore : 0.02 Cr
Latest Charge Details
Date Lender Amount Status
13 Aug 2018 Others ₹0.26 M Open
18 Dec 2015 Icici Bank Limited ₹0.23 M Open
17 Oct 2001 State Bank Of Indore ₹0.20 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Basil Drugs?

Unlock and access historical data on people associated with Basil Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Basil Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Basil Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Basil Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Basil Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Basil Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 0.26 M with Charge ID 100207896 was registered on 13 Aug 2018. was documented.

  • Charges

    Progress on A charge with Icici Bank Limited amounted to Rs. 0.23 M with Charge ID 10620077 was registered on 18 Dec 2015. was documented.

  • Director Appointment

    Mohammad Shakil Sheikh was appointed as a Whole-time director was appointed as a Whole-time director on 30 Sep 2007 & has been associated with this company since 18 years 4 months . was recorded as a recent event.

  • Charges

    The activity A charge with State Bank Of Indore of Rs. 0.20 M registered on 17 Oct 2001 with Charge ID 90203856 was modified on 10 Nov 2004. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Basil Drugs Private Limited?

The CIN of Basil Drugs Private Limited is U24232MP2001PTC014624.

Where is Basil Drugs Private Limited headquartered?

Basil Drugs Private Limited is headquartered at N- 60, Anoop Nagar, Indore, Madhya Pradesh, 452011.

When was Basil Drugs Private Limited incorporated?

Basil Drugs Private Limited was incorporated on 16 April 2001.

Who are the current directors of Basil Drugs Private Limited?

The current directors of Basil Drugs Private Limited are

What is the primary industry of Basil Drugs Private Limited?

The primary industry of Basil Drugs Private Limited is Trade.

Is Basil Drugs Private Limited a listed company?

Basil Drugs Private Limited is unlisted.

What is the capital structure of Basil Drugs Private Limited?

The authorized capital of Basil Drugs Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Basil Drugs Private Limited?

The compliance status of Basil Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available